Candida nivariensis: Identification strategy in mycological laboratories - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Journal of Medical Mycology = Journal de Mycologie Médicale Année : 2020

Candida nivariensis: Identification strategy in mycological laboratories

Résumé

Candida nivariensis is a cryptic fungal species classified within the Candida glabrata complex. It was described for the first time in 2005 by the means of DNA sequencing. We report a rare case of C. nivariensis deep-seated infection occurring in a 77-year-old man hospitalized for cysto-prostatectomy. Phenotypic testing based on the direct examination and the macroscopic features of the in vitro culture initially suggested C. glabrata species, while MALDI-TOF mass spectrometry enables correct identification. The isolate was found resistant to fluconazole, like in almost 20% of the reported cases. Herein, we present our practical strategy to reliably characterize this rare cryptic species. To date, MALDI-TOF mass spectrometry-based analysis showed very good results for such a purpose.
Fichier principal
Vignette du fichier
VERSION_FINALE_tables_et_figures.pdf (505.8 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03382407 , version 1 (28-06-2022)

Identifiants

Citer

Noémie Cartier, Adélaïde Chesnay, Camille Thorey, Diama N’diaye, Marion Ferreira, et al.. Candida nivariensis: Identification strategy in mycological laboratories. Journal of Medical Mycology = Journal de Mycologie Médicale, 2020, 30 (4), pp.101042. ⟨10.1016/j.mycmed.2020.101042⟩. ⟨hal-03382407⟩
107 Consultations
37 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More